Skip to main content
Year archive

Pharmsville Co., Ltd. — 2023 filings

All 18 regulatory filings released by Pharmsville Co., Ltd. (318010) in 2023, sourced directly from the official regulator.

18 Filings
2023 Period
2023 filings (18)
Filing Released Lang
신탁계약에의한취득상황보고서
Transaction in Own Shares
2023-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-14 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-20 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2023-09-15 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-22 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-04 Korean
[기재정정]사업보고서 (2022.12)
Annual Report FY 2022
2023-04-20 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-22 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-20 Korean
주주총회소집공고
AGM Information
2023-03-14 Korean
주주총회소집결의
AGM Information
2023-03-13 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2023-03-13 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-06 Korean